Active Program definition

Active Program means with respect to a Gene Target and a Party, any ongoing drug discovery, development, or commercialization of a compound directed to such Gene Target being conducted by such Party (whether on its own or through a sublicensee).

Active Program shall have the meaning set forth in Section 2.3(a).

Active Program means a Program for a Product that is being purchased and sold under this Agreement that has not yet undergone an End of Life.

Examples of Active Program in a sentence

• Program changes to move project phases from the Contingency Program to the Active Program will occur no later than June 30.

• If a significant risk of an adverse impact on regulatory performance is identified, an organizational change is closely monitored using the Corrective Active Program (CAP), described in Section 3.8 of this License Application, until the risk is resolved.

• Active Program Management begins with the development of a program of projects.

• If during a project’s time on the Contingency List, the project is not moved to the Active Program, the project shall receive an additional 15 points during the next call for projects if the sponsor re-submits an STP application for the project.

• Active Program Management (APM) provides both a mechanism for ensuring timely obligations to protect the region’s funding from lapse and rescission, and to provide flexibility for moving forward projects that are “ready” in favor of those that are “delayed.” APM is achieved through strong project and program management with active monitoring of project implementation status from project selection through obligation of federal funds.

More Definitions of Active Program

Active Program means an active, funded, relevant and ongoing research and development or commercial development

Active Program means a registered program that has:

Active Program means with respect to a gene target, any ongoing drug discovery, development, or commercialization of a compound by Isis (either on its own or in collaboration with a Third Party) directed to such gene target.

Active Program means with respect to an RNA Target and a Party, any ongoing drug discovery, development, or commercialization of a compound directed to such RNA Target being conducted by such Party (whether on its own or through a sublicensee).

Active Program means any research, development or commercialization activities by RBNC or its Affiliates intended to advance and obtain the regulatory approval of and commercialize a Collaboration Derived Product for the treatment of a CNS Disease in which [***]. For clarity, [***].

Active Program in relation to a Collaboration Compound or Product means an ongoing program for optimizing, developing and commercializing such Collaboration Compound or Product, including preclinical studies, human clinical studies, development activities aimed at obtaining registration for marketing, and marketing and selling activities. Except as set forth in Section 2.2(b), an Active Program includes the following specific “Development Milestones” that must be met in order for the Collaboration Compound or Product to achieve and maintain “Active Development” status:

Active Program means with respect to a Gene Target, an Ercole-AVI Exclusive Target or an AVI Exclusive Target, any reasonable (as defined below) ongoing research, development, or commercialization (including research, development or commercialization activities conducted by a Third Party pursuant to a valid sublicense under this Agreement), of a Product directed to such Gene Target. For purposes of clarification, research, development and commercialization efforts with respect to an Ercole-AVI Exclusive Target or an AVI Exclusive Target or Product shall be deemed reasonable if the applicable Party’s research and development efforts with respect to such Gene Target or Product are reasonably comparable with other projects in such Party’s portfolio at a similar stage of development and of similar market potential. Reasonable research, development and commercialization efforts should include preclinical studies, human clinical studies and development aimed at obtaining regulatory approval for marketing a Product that modulates such Gene Target.